ClinicalTrials.Veeva

Menu

Valsalva Maneuver in Thyroidectomy

U

University of Foggia

Status

Completed

Conditions

The Role of Valsalva Manoeuvre, in Thyroidectomy to Reduce Postoperative Bleeding

Treatments

Procedure: Valsalva maneuver

Study type

Observational

Funder types

Other

Identifiers

NCT05474261
UFoggia2

Details and patient eligibility

About

Bleeding after total thyroidectomy remains a rare event that affects early postoperative morbidity, occurring in 0.3% up to 4.2% of cases. Intraoperative bleeding is an unpleasant complication, and it is often easily manageable though postoperative bleeding may represent a life-threatening condition for the patient.

Between January 2019 to February 2022 , 250 consecutive patients were listed for thyroidectomy. The Investigators selected 178 patients and divided them in two groups based on the execution of the Valsalva Manoeuvre.

The purpose of the investigator is to clarify whether the routine intraoperative execution of a Valsalva manoeuvre (VM) may affect the detection of bleeding that would otherwise remain occult and therefore may manifest in the postoperative period.

Enrollment

178 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • thyroid diseases

Exclusion criteria

  • lymph node dissection
  • minimally invasive approaches
  • high anesthesiological risk

Trial design

178 participants in 2 patient groups

GROUP A-NO Valsalva maneuver
GROUP B- Valsalva maneuver
Treatment:
Procedure: Valsalva maneuver

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems